Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma

A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma

Fred Saad, Donald M. Gleason, Robin Murray et al. · JNCI Journal of the National Cancer Institute · 2002 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Structure-Activity Relationships for Inhibition of Farnesyl Diphosphate Synthase in Vitro and Inhibition of Bone Resorption in Vivo by Nitrogen-Containing Bisphosphonates

James E. Dunford, Keith Thompson, Fraser P. Coxon et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 896 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells

Hans-Jürgen Gober, Magdalena Kistowska, Lena Ångman et al. · The Journal of Experimental Medicine · 2003 · 829 citations · Full text

Medicine, Immunology, Oncology +17

Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

Ingo Diel, Erich‐Franz Solomayer, Serban Dan Costa et al. · New England Journal of Medicine · 1998 · 812 citations · Full text

Medicine, Oncology, Pharmacology +16

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Lee S. Rosen, David Gordon, Simon Tchekmedyian et al. · Journal of Clinical Oncology · 2003 · 727 citations

Medicine, Oncology, Pharmacotherapy +17